Skip to main content

Table 2 Medication profile of heart failure patients based on ejection fraction

From: Patients with HFpEF and HFrEF have different clinical characteristics but similar prognosis: a retrospective cohort study

Medication

LVEF ≥ 50 (n,164)

LVEF < 50% (n,147)

P value

ACEI n, %

34 (15.85)

80 (40.82)

<0.001

Beta Blocker n, %

45 (21.95)

73 (36.73)

<0.001

Diuretics n, %

146 (74.39)

136 (70.75)

0.290

Spironolactone n, %

114 (57.93)

95 (48.99)

0.359

Digoxin n, %

46 (23.17)

33 (17.69)

0.257

Statin n, %

24 (11.59)

30 (13.61)

0.180

Anticoagulants n, %

33 (17.07)

12 (14.70)

0.003

Antiplatelet agents n, %

33 (15.24)

39 (17.69)

0.181

CCB n, %

21 (9.76)

7 (4.76)

0.013

  1. ACEI angiotensin converting enzyme inhibitor, CCB calcium channel blocker